Provided by Tiger Trade Technology Pte. Ltd.

Merck

129.38
+0.72000.56%
Pre-market: 128.82-0.5600-0.43%04:44 EDT
Volume:9.58M
Turnover:1.24B
Market Cap:321.12B
PE:36.18
High:129.97
Open:127.65
Low:126.74
Close:128.66
52wk High:129.97
52wk Low:76.66
Shares:2.48B
Float Shares:2.48B
Volume Ratio:0.74
T/O Rate:0.39%
Dividend:3.28
Dividend Rate:2.54%
EPS(TTM):3.58
EPS(LYR):7.28
ROE:18.94%
ROA:12.58%
PB:7.00
PE(LYR):17.77

Loading ...

Scotiabank Raises Merck Price Target to $155 From $136, Sector Outperform Rating Kept

MT Newswires Live
·
14 hours ago

Merck price target raised to $155 from $136 at Scotiabank

TIPRANKS
·
14 hours ago

Merck Agrees With ADAP Crisis Task Force to Provide Access to HIV Treatment Idvynso

MT Newswires Live
·
Yesterday

Merck Says FDA Approves Once-daily HIV Combo Pill Idvynso

Reuters
·
Yesterday

Merck Announces New Agreement with Adap Crisis Task Force to Improve Access and Care for People Living with Hiv

THOMSON REUTERS
·
Yesterday

Weekly Winners | Bio-Techne Soars 23%; AbbVie Surges 17%; United Airlines Jumps 15%; Corning, Merck Gain 13%

Tiger Newspress
·
Jun 28

Health Care Roundup: Market Talk

Dow Jones
·
Jun 27

Merck & Co. Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jun 27

US Starts Vaccine Effort for Ebola Bundibugyo as Outbreak Spreads

Reuters
·
Jun 27

Merck (MRK) Stock After 64% One-Year Rally And Terns Deal Is It Priced Fairly?

Simply Wall St.
·
Jun 26

Qualcomm, Merck, Rockwell Automation And A Real Estate Stock On CNBC’s ‘Final Trades’

Benzinga
·
Jun 26

UBS Remains a Buy on Merck KGaA (0O14)

TIPRANKS
·
Jun 26

Barclays Sticks to Their Buy Rating for Merck & Company (MRK)

TIPRANKS
·
Jun 26

Barclays Reaffirms Their Hold Rating on Merck KGaA (0O14)

TIPRANKS
·
Jun 26

PRESS Digest-financial Times - June 26

Reuters
·
Jun 26

Movement Alert|Merck Rises 3.08% in Regular Trading, Keytruda Plus Trodelvy Wins FDA Approval for Triple-Negative Breast Cancer

Market Focus
·
Jun 26

The Dow Hits Record High, Caterpillar Surges Over 5%

Tiger Newspress
·
Jun 25

Bio-Techne Surges as Merck Agrees to Acquire Company at $73 Per Share in Cash

Market Focus
·
Jun 25

Merck Gains FDA Approval for Keytruda Plus Trodelvy in PD-L1 Positive Breast Cancer

MT Newswires Live
·
Jun 25

Merck says FDA approves Keytruda and Keytruda Qlex in combo with Trodelvy

TIPRANKS
·
Jun 25